| scholarly article | Q13442814 |
| P50 | author | Cinthia B Drachenberg | Q88971263 |
| Susan R Mendley | Q90587490 | ||
| John C Papadimitriou | Q104508802 | ||
| P2093 | author name string | Hans H Hirsch | |
| Emilio Ramos | |||
| Ravinder Wali | |||
| Ayesa Mian | |||
| Charles B Cangro | |||
| Clinton Crowder | |||
| Joseph Nogueira | |||
| P2860 | cites work | BK virus nephropathy--polyomavirus adding insult to injury | Q28218151 |
| Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation | Q34719108 | ||
| Polyomavirus BK. | Q35548648 | ||
| Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys | Q35786790 | ||
| Persistence of DNA Sequences of BK Virus and JC Virus in Normal Human Tissues and in Diseased Tissues | Q41555932 | ||
| Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis | Q43605141 | ||
| Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology | Q44051167 | ||
| Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients | Q44104230 | ||
| Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches | Q44419275 | ||
| Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs | Q44441935 | ||
| Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy | Q44503856 | ||
| Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis, and Graft Function Following Changes in Immunosuppression | Q44606338 | ||
| Improved outcome of polyoma virus allograft nephropathy with early biopsy | Q44863789 | ||
| Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology | Q45747743 | ||
| Human polyoma virus-associated interstitial nephritis in the allograft kidney | Q45751593 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney disease | Q1054718 |
| viral load | Q2528140 | ||
| P304 | page(s) | 2082-2092 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load | |
| P478 | volume | 4 |
| Q40572871 | 1,25 Dihydroxyvitamin D circulating levels, calcitriol administration, and incidence of acute rejection, CMV infection, and polyoma virus infection in renal transplant recipients |
| Q40631605 | A Preliminary Study Into the Significance of Intrarenal Reflux in BK Virus Nephropathy After Kidney Transplantation |
| Q46707090 | A case of polyomavirus-associated nephropathy presenting late after transplantation |
| Q46582078 | Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. |
| Q45397113 | Adverse impact of pretransplant polyoma virus infection on renal allograft function. |
| Q36947285 | Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies |
| Q47593533 | Animal models of polyomavirus nephropathy: hope and reality |
| Q37302119 | Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients |
| Q36723806 | Antivirals for the treatment of polyomavirus BK replication |
| Q59352951 | BK Polyomavirus MicroRNA Levels in Exosomes Are Modulated by Non-Coding Control Region Activity and Down-Regulate Viral Replication When Delivered to Non-Infected Cells Prior to Infection |
| Q40281578 | BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study |
| Q39180715 | BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies. |
| Q38570451 | BK Virus Nephropathy in Kidney Transplantation: An Approach Proposal and Update on Risk Factors, Diagnosis, and Treatment |
| Q40260844 | BK Virus Nephropathy: Histological Evolution by Sequential Pathology |
| Q98612877 | BK Virus Nephropathy: Prevalence, Impact and Management Strategies |
| Q42124720 | BK Virus-Associated Nephropathy in Kidney Transplant Recipients |
| Q26764877 | BK polyoma virus infection and renal disease in non-renal solid organ transplantation |
| Q42272314 | BK polyomavirus in solid organ transplantation |
| Q37879442 | BK polyomavirus infection and nephropathy: the virus-immune system interplay. |
| Q45160805 | BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report |
| Q36505713 | BK virus infection in transplant recipients: an overview and update |
| Q37296969 | BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants |
| Q36766487 | BK virus infection, replication, and diseases in pediatric kidney transplantation. |
| Q43184361 | BK virus large T and VP-1 expression in infected human renal allografts |
| Q80794360 | BK virus nephritis after renal transplantation |
| Q36361588 | BK virus nephritis after renal transplantation |
| Q34509585 | BK virus nephropathy in renal transplant recipients |
| Q44025547 | BK virus-associated nephropathy: neutrophil gelatinase-associated lipocalin as a new diagnostic tool? |
| Q36188861 | BK virus: opportunity makes a pathogen |
| Q30371017 | Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts. |
| Q37738744 | Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin |
| Q39155699 | Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature |
| Q36400852 | Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis. |
| Q44763558 | Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy |
| Q43530174 | Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy |
| Q30681903 | Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival |
| Q24672593 | Development of a loop-mediated isothermal amplification assay for rapid detection of BK virus |
| Q90418775 | Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation |
| Q40955618 | Different risk factor profiles distinguish early-onset from late-onset BKV-replication |
| Q38926133 | Distinct BK polyomavirus non-coding control region (NCCR) variants in oral fluids of HIV- associated Salivary Gland Disease patients |
| Q44295073 | Does JC Polyomavirus Cause Nephropathy in Renal Transplant Patients? |
| Q92559982 | Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor |
| Q41271481 | Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy |
| Q51872452 | Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience. |
| Q36257694 | Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus -Associated Nephropathy after Renal Transplantation |
| Q40351825 | HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity |
| Q37191661 | High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype |
| Q37260167 | High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients |
| Q40236939 | Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings |
| Q38154130 | Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation |
| Q42414994 | Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis? |
| Q55026903 | Identification of potential key protein interaction networks of BK virus nephropathy in patients receiving kidney transplantation. |
| Q37127201 | Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity |
| Q45356490 | Immunohistochemical features of BK virus nephropathy in renal transplant recipients |
| Q37249853 | Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection |
| Q45402370 | Immunosuppression reduction for BK virus nephropathy: a case for caution |
| Q47212150 | Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function. |
| Q45384299 | Impact of preemptive reduction of immunosuppression with serial monitoring for BK virus replication in renal transplant recipients undergoing short-term evaluation |
| Q36126901 | Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients |
| Q45367418 | Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. |
| Q40689820 | Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy. |
| Q43426992 | Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). |
| Q43283964 | Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection |
| Q33376066 | Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation |
| Q38003050 | Management of polyomavirus-associated nephropathy in renal transplant recipients |
| Q44746525 | Mannose-binding lectin deficiency is not associated with increased risk for polyomavirus nephropathy |
| Q41532326 | Molecular detection and characterization of BK and JC polyomaviruses in urine samples of renal transplant patients in Southern Brazil |
| Q37848137 | Monitoring and managing viral infections in pediatric renal transplant recipients |
| Q46268984 | Mutations in the BC-loop of the BKV VP1 region do not influence viral load in renal transplant patients |
| Q45326184 | Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. |
| Q92068281 | Non-invasive urinary sediment double-immunostaining predicts BK polyomavirus associated-nephropathy in kidney transplant recipients |
| Q37631149 | Noninvasive prognostication of polyomavirus BK virus-associated nephropathy |
| Q38269958 | Observations on the use of cidofovir for BK virus infection in renal transplantation |
| Q38006194 | Other viral infections in solid organ transplantation |
| Q43666740 | PCR assays for the early detection of BKV infection in 125 Spanish kidney transplant patients |
| Q51873284 | Pathology of resolving polyomavirus-associated nephropathy. |
| Q38940498 | Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe |
| Q35104851 | Polyclonal gammopathy after BKV infection in HSCT recipient: a novel trigger for plasma cells replication? |
| Q47556851 | Polyoma virus nephropathy in kidney transplantation. |
| Q36537931 | Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology |
| Q85125676 | Polyomavirus infection and urothelial carcinoma |
| Q38022715 | Polyomavirus nephropathy - recent pathological diagnostic problems and the report from the 2011 Banff meeting |
| Q36642850 | Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat |
| Q36492403 | Polyomavirus-associated nephropathy: update in diagnosis |
| Q36492408 | Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients |
| Q28081350 | Polyomaviruses and disease: is there more to know than viremia and viruria? |
| Q34435191 | Post-transplant infections: An ounce of prevention. |
| Q45374024 | Preemptive Retransplant for BK Virus Nephropathy Without Concurrent Transplant Nephrectomy |
| Q45420479 | Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia |
| Q37086685 | Presence of urinary Haufen accurately predicts polyomavirus nephropathy |
| Q46246100 | Prospective study of infection and nephropathy due to BK and JC polyomavirus in 76 kidney transplant recipients |
| Q47830873 | Proteinuria in pediatric renal transplant recipients. |
| Q33905299 | Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations |
| Q52845695 | Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. |
| Q42343473 | Renal association clinical practice guideline in post-operative care in the kidney transplant recipient |
| Q35986282 | Review article: BK virus in systemic lupus erythematosus |
| Q37102082 | Risk factors for polyoma virus nephropathy |
| Q36272108 | Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients |
| Q36297604 | Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement. |
| Q40835812 | Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy |
| Q40329754 | Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy |
| Q42217747 | Successful treatment of BK virus nephropathy using therapeutic drug monitoring of mycophenolic acid |
| Q30224990 | Systematic screening of BK virus by real-time PCR prevents BK virus associated nephropathy in renal transplant recipients |
| Q42270935 | TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology. |
| Q42276202 | Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients |
| Q37821326 | The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment |
| Q35870126 | The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome |
| Q47246603 | The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations. |
| Q28085440 | The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation |
| Q90176540 | The immunophenotyping of different stages of BK virus allograft nephropathy |
| Q28292658 | The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation |
| Q80166793 | The natural history, risk factors and outcomes of polyomavirus BK-associated nephropathy after renal transplantation |
| Q38247690 | The significance of histological diagnosis in renal allograft biopsies in 2014. |
| Q37621575 | Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation |
| Q91795420 | Transplant renal artery stenosis in a child with BK nephropathy |
| Q42195428 | Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child |
| Q44289326 | Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation |
| Q33282590 | Ultrastructural observations in a case of BK virus nephropathy with viruses in glomerular subepithelial humps |
| Q99711497 | Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection |
| Q36014205 | Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experience |
| Q34337472 | Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers |
| Q40291483 | Variability in assessing for BK viremia: whole blood is not reliable and plasma is not above reproach - a retrospective analysis. |
| Q45251363 | Viral Haufen are urinary biomarkers of polyomavirus nephropathy: New diagnostic strategies utilizing negative staining electron microscopy |
| Q36863402 | Viral dynamics in transplant patients: implications for disease |
| Q84522900 | [BK virus nephropathy after kidney transplantation] |
| Q81635113 | [Infections after organ transplantation] |
Search more.